Medi-Ject moves ahead with needle-free device
This article was originally published in Clinica
Executive Summary
Medi-Ject claims to have made an important development with its potential alternative drug delivery method for the treatment of male impotence. It has completed an initial study of its needle-free injector using a dye solution to test the device for acute tissue trauma. The Minneapolis, Minnesota-based company's chairman and CEO, Dr Franklin Pass, said the study was a crucial first step in bringing to market a needle-free intrapenile delivery system for vasoactive drugs.